Transformer 2β and miR-204 regulate apoptosis through competitive binding to 3′ UTR of BCL2 mRNA

Cell Death and Differentiation

Volumn 22, Issue 5, 2015, Pages 815-825

  Kuwano, Y ^a   Nishida, K ^a   Kajita, K ^a   Satake, Y ^a   Akaike, Y ^a   Fujita, K ^a   Kano, S ^a   Masuda, K ^a   Rokutan, K ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; BCL2 PROTEIN, HUMAN; MICRORNA; MIRN204 MICRORNA, HUMAN; NERVE PROTEIN; PROTEIN BCL 2; RNA; RNA BINDING PROTEIN; TRA2B PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; APOPTOSIS; BIOSYNTHESIS; COLON TUMOR; GENETICS; HEK293 CELL LINE; HELA CELL LINE; HUMAN; METABOLISM; PATHOLOGY;

3' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; APOPTOSIS; COLONIC NEOPLASMS; HEK293 CELLS; HELA CELLS; HUMANS; MICRORNAS; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, NEOPLASM; RNA-BINDING PROTEINS;

EID: 84928340238     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.176     Document Type: Article

References (47)

1. Mayeda A, Zahler AM, Krainer AR, Roth MB. Two members of a conserved family of nuclear phosphoproteins are involved in pre-mRNA splicing. Proc Natl Acad Sci USA 1992; 89: 1301-1304.
2. Tacke R, Tohyama M, Ogawa S, Manley JL. Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 1998; 93: 139-148.
3. Nayler O, Cap C, Stamm S. Human transformer-2-beta gene (SFRS10): complete nucleotide sequence, chromosomal localization, and generation of a tissue-specific isoform. Genomics 1998; 53: 191-202.
4. Shepard PJ, Hertel KJ. The SR protein family. Genome Biol 2009; 10: 242.
5. Daoud R, Da Penha Berzaghi M, Siedler F, Hübener M, Stamm S. Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur J Neurosci 1999; 11: 788-802.
6. Dauwalder B, Amaya-Manzanares F, Mattox W. A human homologue of the Drosophila sex determination factor transformer-2 has conserved splicing regulatory functions. Proc Natl Acad Sci USA 1996; 93: 9004-9009.
7. Beil B, Screaton G, Stamm S. Molecular cloning of htra2-beta-1 and htra2-beta-2, two human homologs of tra-2 generated by alternative splicing. DNA Cell Biol 1997; 16: 679-690.
8. Shen H, Kan JL, Green MR. Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly. Mol Cell 2004; 13: 367-376.
9. Grellscheid S, Dalgliesh C, Storbeck M, Best A, Liu Y, Jakubik M et al. Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2β in development. PLoS Genet 2011; 7: e1002390.
10. Cléry A, Jayne S, Benderska N, Dominguez C, Stamm S, Allain FH. Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-β1. Nat Struct Mol Biol 2011; 18: 443-450.
11. Hofmann Y, Lorson CL, Stamm S, Androphy EJ, Wirth B. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci USA 2000; 97: 9618-9623.
12. Kondo S, Yamamoto N, Murakami T, Okumura M, Mayeda A, Imaizumi K. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA. Genes Cells 2004; 9: 121-130.
13. Tsuda K, Someya T, Kuwasako K, Takahashi M, He F, Unzai S et al. Structural basis for the dual RNA-recognition modes of human Tra2-β RRM. Nucleic Acids Res 2011; 39: 1538-1553.
14. Watermann DO, Tang Y, Zur Hausen A, Jäger M, Stamm S, Stickeler E. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res 2006; 66: 4774-4780.
15. Fischer DC, Noack K, Runnebaum IB, Watermann DO, Kieback DG, Stamm S et al. Expression of splicing factors in human ovarian cancer. Oncol Rep 2004; 11: 1085-1090.
16. Mende Y, Jakubik M, Riessland M, Schoenen F, Rossbach K, Kleinridders A et al. Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing. Hum Mol Genet 2010; 19: 2154-2167.
17. Long JC, Caceres JF. The SR protein family of splicing factors: master regulators of gene expression. Biochem J 2009; 417: 15-27.
18. Loomis RJ, Naoe Y, Parker JB, Savic V, Bozovsky MR, Macfarlan T et al. Chromatin binding of SRp20 and ASF/SF2 and dissociation from mitotic chromosomes is modulated by histone H3 serine 10 phosphorylation. Mol Cell 2009; 33: 450-461.
19. Michlewski G, Sanford JR, Cáceres JF. The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1. Mol Cell 2008; 30: 179-189.
20. Pelisch F, Gerez J, Druker J, Schor IE, Muñoz MJ, Risso G et al. The serine/arginine-rich protein SF2/ASF regulates protein sumoylation. Proc Natl Acad Sci USA 2010; 107: 16119-16124.
21. Wu H, Sun S, Tu K, Gao Y, Xie B, Krainer AR et al. A splicing-independent function of SF2/ASF in microRNA processing. Mol Cell 2010; 38: 67-77.
22. Tsukamoto Y, Matsuo N, Ozawa K, Hori O, Higashi T, Nishizaki J et al. Expression of a novel RNA-splicing factor, RA301/Tra2beta, in vascular lesions and its role in smooth muscle cell proliferation. Am J Pathol 2001; 158: 1685-1694.
23. Gabriel B, Zur Hausen A, Bouda J, Boudova L, Koprivova M, Hirschfeld M et al. Significance of nuclear hTra2-beta1 expression in cervical cancer. Acta Obstet Gynecol Scand 2009; 88: 216-221.
24. Kajita K, Kuwano Y, Kitamura N, Satake Y, Nishida K, Kurokawa K et al. Ets1 and heat shock factor 1 regulate transcription of the Transformer 2β gene in human colon cancer cells. J Gastroenterol 2013; 48: 1222-1233.
25. Ishimaru D, Ramalingam S, Sengupta TK, Bandyopadhyay S, Dellis S, Tholanikunnel BG et al. Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells. Mol Cancer Res 2009; 7: 1354-1366.
26. Filippova N, Yang X, Wang Y, Gillespie GY, Langford C, King PH et al. The RNA-binding protein HuR promotes glioma growth and treatment resistance. Mol Cancer Res 2011; 9: 648-659.
27. Moore MJ, Wang Q, Kennedy CJ, Silver PA. An alternative splicing network links cell-cycle control to apoptosis. Cell 2010; 142: 625-636.
28. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 9: 839-845.
29. Jiang Y, Xu XS, Russell JE. A nucleolin-binding 3' untranslated region element stabilizes beta-globin mRNA in vivo. Mol Cell Biol 2006; 26: 2419-2429.
30. Abdelmohsen K, Tominaga K, Lee EK, Srikantan S, Kang MJ, Kim MM et al. Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs. Nucleic Acids Res 2011; 39: 8513-8530.
31. Sun D, Novotny M, Bulek K, Liu C, Li X, Hamilton T. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat Immunol 2011; 12: 853-860.
32. Qian W, Iqbal K, Grundke-Iqbal I, Gong CX, Liu F. Splicing factor SC35 promotes tau expression through stabilization of its mRNA. FEBS Lett 2011; 585: 875-880.
33. Srikantan S, Abdelmohsen K, Lee EK, Tominaga K, Subaran SS, Kuwano Y et al. Translational control of TOP2A influences doxorubicin efficacy. Mol Cell Biol 2011; 31: 3790-3801.
34. Kim HH, Kuwano Y, Srikantan S, Lee EK, Martindale JL, Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 2009; 23: 1743-1748.
35. Lebedeva S, Jens M, Theil K, Schwanhäusser B, Selbach M, Landthaler M et al. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell 2011; 43: 340-352.
36. Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev S, Hafner M et al. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol Cell 2011; 43: 327-339.
37. Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, Siu NS et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer 2012; 130: 1036-1045.
38. Lam EK, Wang X, Shin VY, Zhang S, Morrison H, Sun J et al. A microRNA contribution to aberrant Ras activation in gastric cancer. Am J Transl Res 2011; 3: 209-218.
39. Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 2012; 21: 532-546.
40. Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A et al. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer 2013; 132: 2479-2491.
41. Sacconi A, Biagioni F, Canu V, Mori F, Di Benedetto A, Lorenzon L et al. miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis 2012; 3: e423.
42. Chen Z, Sangwan V, Banerjee S, Mackenzie T, Dudeja V, Li X et al. miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death. Mol Cancer 2013; 12: 105.
43. Bao W, Wang HH, Tian FJ, He XY, Qiu MT, Wang JY et al. A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol Cancer 2013; 12: 155.
44. Imam JS, Plyler JR, Bansal H, Prajapati S, Bansal S, Rebeles J et al. Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/ mTOR/Rac1 signaling and actin reorganization. PLoS One 2012; 7: e52397.
45. Imam SZ, Trickler W, Kimura S, Binienda ZK, Paule MG, Slikker W et al. Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson's disease model. PLoS One 2013; 8: e65129.
46. Kurokawa K, Akaike Y, Masuda K, Kuwano Y, Nishida K, Yamagishi N et al. Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells. Oncogene 2013; 33: 1407-1417.
47. Masuda K, Kuwano Y, Nishida K, Rokutan K. Application of DNA microarray technology to gerontological studies. Methods Mol Biol 2013; 1048: 285-308.